Clinical Trial Update: Avastin as an Adjunct to Diode Laser in the Treatment of Neovascular Glaucoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating bevacizumab (Avastin) as an adjunct to diode laser treatment for neovascular glaucoma has completed. The study is sponsored by Cairo …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Glaucoma

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Cairo University | Conditions: Neovascular Glaucoma | Phase 2 | Status: COMPLETED